Skip to main content
. 2012 Sep 18;107(9):1525–1533. doi: 10.1038/bjc.2012.421

Table 1. Patient characteristics and toxicity by 5FU treatment regimen.

  Treatment regimen
  Mayo daily schedule Weekly schedule
  n =42 n =31
5FU (mg m−2) 425 500
LV (mg m−2) 20 20
Schedule Daily for 5 days every 4 weeks Weekly for 4 weeks
     
Gender, n (%)
 Male 24 (57) 18 (58)
 Female 18 (43) 13 (42)
Age (years) 62 (58–66) 64 (54–72)
     
CRC, n (%)
 Stage B 5 (12) 6 (19)
 Stage C 37 (88) 25 (81)
Platelet nadir (109 l−1) 231 (196–269) 236 (215–258)
WBC nadir (109 l−1) 3.7 (2.6–4.7) 4.8 (4.1–6.4)
ANC nadir (109 l−1) 0.7 (0.3–2.0) 2.6 (1.7–3.7)
     
Thrombocytopenia, n (%)
 Grade 4 1 (2) 0 (0)
     
Leukopenia, n (%)
 Grade 1 4 (10) 3 (10)
 Grade 2 11 (27) 1 (3)
 Grade 3 3 (7) 1 (3)
 Grade 4 1 (2) 0 (0)
     
Neutropenia, n (%)
 Grade 1 2 (5) 6 (19)
 Grade 2 5 (12) 2 (6)
 Grade 3 8 (20) 1 (3)
 Grade 4 13 (32) 0 (0)
     
Haematological toxicity
 ⩾Grade1 29 (70) 10 (32)
     
Febrile neutropenia, n (%)
 Grade 3 1 (2) 1 (3)
 Grade 4 2 (5) 0 (0)
     
Mucositis, n (%)
 Grade 1 4 (10) 2 (6)
 Grade 2 15 (36) 2 (6)
 Grade 3 5 (12) 0 (0)
     
Diarrhoea, n (%)
 Grade 1 17 (40) 8 (26)
 Grade 2 3 (7) 3 (10)
 Grade 3 2 (5) 2 (6)

Abbreviations: 5FU=5-Fluorouracil; ANC=absolute neutrophil count; CRC=colorectal cancer; LV=leucovorin; WBC=white blood count.

Values for non categorical data are median (lower–upper quartile).